H.R. 1843 · 119th Congress

To amend the Federal Food, Drug, and Cosmetic Act to increase transparency in generic drug applications.

Stage
In committee
Sponsor
Neal Dunn
Introduced
2025-03-05
Latest action
2025-03-05 · Introduced in House

Text